YK-11 is a selective androgen receptor myostatin inhibitor that accelerates the expression of follistatin. Follistatin, a myostatin and activin-binding protein that occurs naturally in humans, has been used to treat a variety of degenerative muscle diseases. When follistatin levels are elevated, myostatin levels will be suppressed. Inhibiting myostatin increases muscle mass and improves strength.